Form 8-K - Current report:
SEC Accession No. 0001193125-24-221120
Filing Date
2024-09-18
Accepted
2024-09-18 09:18:29
Documents
18
Period of Report
2024-09-18
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823642d8k.htm   iXBRL 8-K 41701
2 EX-3.1 d823642dex31.htm EX-3.1 7883
3 EX-3.2 d823642dex32.htm EX-3.2 69284
4 EX-99.1 d823642dex991.htm EX-99.1 13902
8 GRAPHIC g823642g0918070107573.jpg GRAPHIC 2650
9 GRAPHIC g823642g0918070107956.jpg GRAPHIC 2542
  Complete submission text file 0001193125-24-221120.txt   298504

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gthx-20240918.xsd EX-101.SCH 2871
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20240918_lab.xml EX-101.LAB 18739
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20240918_pre.xml EX-101.PRE 11721
20 EXTRACTED XBRL INSTANCE DOCUMENT d823642d8k_htm.xml XML 3861
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 241306304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)